drugset / Trial / NCT01338610
ESBA105 in Patients With Severe Dry Eye
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy of ESBA105 over vehicle in reducing the ocular symptoms of dry eye disease, as measured by a mean global Visual Analog Scale (VAS) discomfort score.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESBA105 | Monoclonal antibody | — | Other |